Ambu A/S (OTCMKTS:AMBBY) Sets New 52-Week Low – Here’s Why

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $10.00 and last traded at $10.00, with a volume of 118 shares trading hands. The stock had previously closed at $10.3162.

Ambu A/S Stock Down 3.1%

The company has a current ratio of 2.86, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08. The firm has a market cap of $2.35 billion, a P/E ratio of 32.26 and a beta of 1.25. The company’s 50 day simple moving average is $12.04 and its 200-day simple moving average is $13.56.

Ambu A/S (OTCMKTS:AMBBY) last posted its earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $242.85 million for the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.